Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy
Clinical trial NCT04085250 · UNKNOWN
Trial details
- NCT number
- NCT04085250
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-28
- Primary completion
- 2025-01-31
- Enrollment
- 264
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.